Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer - ScienceDirect

Enhancer of Zeste Homologue 2 (EZH2) is the catalytic subunit of the polycomb repressive complex 2 (PRC2) that is critical for determining cell identi…

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer - ScienceDirect

Overcoming Immune Checkpoint Blockade Resistance via EZH2 Inhibition: Trends in Immunology

Roles of the Polycomb group proteins in stem cells and cancer

Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses - ScienceDirect

Frontiers Easy or Not—The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity

Identification of a cytisine-based EED-EZH2 protein-protein interaction inhibitor preventing metastasis in triple-negative breast cancer cells – ScienceOpen

The molecular mechanisms and therapeutic potential of EZH2 in breast cancer - ScienceDirect

EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells

Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2

Wnt signaling pathway Leaders in Pharmaceutical Business Intelligence (LPBI) Group

IJMS, Free Full-Text

The noncanonical role of EZH2 in cancer - Huang - 2021 - Cancer Science - Wiley Online Library

Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses - ScienceDirect

Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers - ScienceDirect